About Us
We develop, manufacture, market, and distribute high-quality branded pharmaceuticals to meet patient needs, while also producing for other companies and licensing our products to partners in Egypt and the region.
Founded in 2022, CHC (Capital Health Care) was established with a clear and ambitious vision: to position itself as a leading pharmaceutical company in pediatric healthcare through the development and commercialization of a high-quality, premium, and diversified product portfolio.
As an Egyptian pharmaceutical company, CHC is committed to addressing the evolving healthcare needs of Egyptian patients by delivering safe, effective, and reliable therapeutic solutions. The company operates in full alignment with the highest standards of quality, regulatory compliance, and ethical business practices, ensuring that every product meets rigorous scientific and manufacturing benchmarks.
Driven by innovation and patient-centric values, CHC continuously invests in strategic partnerships, market insights, and portfolio expansion to strengthen its presence in the pediatric segment. While maintaining a strong domestic foundation, the company aspires to expand into regional and international markets, contributing to improved healthcare access beyond national borders.
At CHC, our commitment extends beyond business growth. We strive to create sustainable value for our shareholders and partners while upholding our responsibility to patients, healthcare professionals, and the broader community. Through dedication, integrity, and excellence, CHC aims to make a meaningful and lasting impact in pediatric healthcare.